Brief: Arovella Therapeutics Posts FY Total Comprehensive Loss For Year A$8.6 Million
31/08/2022 02:45
Aug 31 (Reuters) - Arovella Therapeutics ALA.AX :
* FY TOTAL COMPREHENSIVE LOSS FOR YEAR A$8.6 MILLION VERSUS
LOSS
OF A$5.0 MILLION
Source text for Eikon: ID:nASXbW6kFT
Further company coverage: ALA.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Arovella Therapeutics
See all newsBrief: Arovella Therapeutics Appoints Acting CEO
Brief: Arovella Therapeutics Says Michael Baker Resigns As CEO
Brief: Arovella Therapeutics Says Elizabeth Stoner Will Be Retiring As Interim Chair
Brief: Arovella Therapeutics Says IND For Ala-101 Accepted By FDA
Brief: Arovella Therapeutics Appoints Lachie Mallia As CFO